Not Yet Recruiting
Phase 1 Study of HS-10541 as Monotherapy or in Combination With Other Anti-cancer Therapies in Patients With KRAS G12C Mutation Advanced Solid Tumors.
NCT07615413
- Conditions
- KRAS G12C Mutation Advanced Solid Tumor
- Locations
-
Not specified